Table 3.
Age-adjusted odds-ratios (OR)a with 95% CI for risk of incident diabetes associated with the metabolic syndrome, among 3,774 D.E.S.I.R. participants followed for 9 years.
| Age-adjusted OR (95% CI) | Men | Women | ||
|---|---|---|---|---|
| Including IFGb at baseline | Excluding IFG at baseline | Including IFG at baseline | Excluding IFG at baseline | |
| (n=1,835) | (n=1,599) | (n=1,939) | (n=1,868) | |
| Cases of diabetes | 122 | 53 | 51 | 25 |
| MetS scorec | 3.4 (2.6, 4.4) | 3.1 (2.2, 4.4) | 5.1 (3.6, 7.2) | 4.1 (2.6, 6.4) |
| MetS-NCEP | 2.4 (1.9, 2.9) | 1.7 (1.2, 2.3) | 3.4 (2.6, 4.4) | 2.5 (1.7, 3.6) |
MetS, metabolic syndrome
a
OR for the MetS score is per 1 standard deviation (SD) increase in the continuous MetS score; OR for MetS-NCEP is per increase of one NCEP abnormality, with a range of 0–5 potential abnormalities as defined by NCEP [6]
b
IFG = 6.1–6.99 mmol/l
c
MetS score, defined from the first principal components analysis with four measures included: waist circumference, log-triglycerides, glucose, systolic blood pressure.